-
Something wrong with this record ?
Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
M. Doubková, M. Karpíšek, J. Mazoch, J. Skřičková, M. Doubek,
Language English Country Italy
Document type Comparative Study, Evaluation Study, Journal Article
PubMed
27758987
Knihovny.cz E-resources
- MeSH
- Biomarkers blood MeSH
- Bronchoalveolar Lavage Fluid chemistry MeSH
- Pulmonary Disease, Chronic Obstructive blood diagnosis mortality MeSH
- Diagnosis, Differential MeSH
- Adult MeSH
- Trefoil Factor-3 blood MeSH
- Idiopathic Pulmonary Fibrosis blood diagnosis mortality MeSH
- Humans MeSH
- Multivariate Analysis MeSH
- Lung diagnostic imaging metabolism physiopathology MeSH
- Sarcoidosis, Pulmonary blood diagnosis mortality MeSH
- Tomography, X-Ray Computed MeSH
- Predictive Value of Tests MeSH
- Prognosis MeSH
- Pulmonary Surfactant-Associated Protein A blood MeSH
- Pulmonary Surfactant-Associated Protein D blood MeSH
- S100 Proteins blood MeSH
- Prostatic Secretory Proteins blood MeSH
- Aged MeSH
- Spirometry MeSH
- Case-Control Studies MeSH
- Severity of Illness Index MeSH
- Uteroglobin blood MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Comparative Study MeSH
BACKGROUND: Identification of serum and bronchoalveolar lavage fluid (BALF) biomarkers may facilitate diagnosis and prognostication in various lung disorders. OBJECTIVE: Serum and BALF levels of surfactant protein A (SP-A), surfactant protein D (SP-D), Clara cell protein 16 (CC16), S100 protein, trefoil factor 3 (TFF3), and prostatic secretory protein 94 (PSP94) were evaluated in 94 consecutive patients (idiopathic pulmonary fibrosis (IPF; n=18), sarcoidosis (n=25), chronic obstructive pulmonary disease (COPD; n=51)), and in 155 healthy controls. METHODS: Biomarkers were measured at diagnosis and compared with disease characteristics. Both uniparametric and multiparametric analyses were used. RESULTS: Seven significant correlations were found: 1) BALF PSP94 level correlated with prognosis of sarcoidosis (P=0.035); 2) BALF SP-D level with pulmonary functions in IPF (P=0.032); 3) BALF SP-D and TFF3 with IPF mortality (P=0.049 and 0.017, respectively); 4) serum TFF3 level with COPD mortality (P=0.006,); 5) serum SP-A with pulmonary functions impairment in IPF (P=0.011); 6) serum SP-D level was associated with HRCT interstitial score in IPF (P=0.0346); and 7) serum SP-A was associated with staging of COPD according to spirometry (P<0.001). Moreover, our analysis showed that some biomarker levels differed significantly among the diseases: 1) BALF SP-D level differed between sarcoidosis and IPF; 2) serum SP-A level differed among IPF, sarcoidosis, COPD and was also different from healthy controls; 3) serum S100A6, S100A11 levels differed among IPF, sarcoidosis, COPD from healthy controls 4) serum SP-D, CC16, TFF-3 levels distinguished IPF patients from healthy controls; and 5) serum CC16, TFF3, PSP94 distinguished COPD patients from healthy controls. Our study shows that some of selected biomarkers should have prognostic value in the analysed lung disorders. On the other hand, these biomarkers do not appear to be unequivocally suitable for differential diagnosis of these disorders.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013471
- 003
- CZ-PrNML
- 005
- 20170426093505.0
- 007
- ta
- 008
- 170413s2016 it f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)27758987
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Doubková, Martina $u Department of Pneumology, University Hospital, Jihlavska 20, 62500 Brno. doubkovamartina@seznam.cz.
- 245 10
- $a Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease / $c M. Doubková, M. Karpíšek, J. Mazoch, J. Skřičková, M. Doubek,
- 520 9_
- $a BACKGROUND: Identification of serum and bronchoalveolar lavage fluid (BALF) biomarkers may facilitate diagnosis and prognostication in various lung disorders. OBJECTIVE: Serum and BALF levels of surfactant protein A (SP-A), surfactant protein D (SP-D), Clara cell protein 16 (CC16), S100 protein, trefoil factor 3 (TFF3), and prostatic secretory protein 94 (PSP94) were evaluated in 94 consecutive patients (idiopathic pulmonary fibrosis (IPF; n=18), sarcoidosis (n=25), chronic obstructive pulmonary disease (COPD; n=51)), and in 155 healthy controls. METHODS: Biomarkers were measured at diagnosis and compared with disease characteristics. Both uniparametric and multiparametric analyses were used. RESULTS: Seven significant correlations were found: 1) BALF PSP94 level correlated with prognosis of sarcoidosis (P=0.035); 2) BALF SP-D level with pulmonary functions in IPF (P=0.032); 3) BALF SP-D and TFF3 with IPF mortality (P=0.049 and 0.017, respectively); 4) serum TFF3 level with COPD mortality (P=0.006,); 5) serum SP-A with pulmonary functions impairment in IPF (P=0.011); 6) serum SP-D level was associated with HRCT interstitial score in IPF (P=0.0346); and 7) serum SP-A was associated with staging of COPD according to spirometry (P<0.001). Moreover, our analysis showed that some biomarker levels differed significantly among the diseases: 1) BALF SP-D level differed between sarcoidosis and IPF; 2) serum SP-A level differed among IPF, sarcoidosis, COPD and was also different from healthy controls; 3) serum S100A6, S100A11 levels differed among IPF, sarcoidosis, COPD from healthy controls 4) serum SP-D, CC16, TFF-3 levels distinguished IPF patients from healthy controls; and 5) serum CC16, TFF3, PSP94 distinguished COPD patients from healthy controls. Our study shows that some of selected biomarkers should have prognostic value in the analysed lung disorders. On the other hand, these biomarkers do not appear to be unequivocally suitable for differential diagnosis of these disorders.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a bronchoalveolární lavážní tekutina $x chemie $7 D001992
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a idiopatická plicní fibróza $x krev $x diagnóza $x mortalita $7 D054990
- 650 _2
- $a plíce $x diagnostické zobrazování $x metabolismus $x patofyziologie $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a sekreční proteiny prostaty $x krev $7 D029584
- 650 _2
- $a chronická obstrukční plicní nemoc $x krev $x diagnóza $x mortalita $7 D029424
- 650 _2
- $a protein A asociovaný s plicním surfaktantem $x krev $7 D037662
- 650 _2
- $a protein D asociovaný s plicním surfaktantem $x krev $7 D037663
- 650 _2
- $a proteiny S100 $x krev $7 D009418
- 650 _2
- $a plicní sarkoidóza $x krev $x diagnóza $x mortalita $7 D017565
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a spirometrie $7 D013147
- 650 _2
- $a počítačová rentgenová tomografie $7 D014057
- 650 _2
- $a faktor TFF3 $x krev $7 D000071165
- 650 _2
- $a uteroglobin $x krev $7 D014598
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karpíšek, Michal
- 700 1_
- $a Mazoch, Jiri
- 700 1_
- $a Skřičková, Jana
- 700 1_
- $a Doubek, Michael
- 773 0_
- $w MED00177336 $t Sarcoidosis, vasculitis, and diffuse lung diseases official journal of WASOG $x 1124-0490 $g Roč. 33, č. 3 (2016), s. 224-234
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27758987 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170426093823 $b ABA008
- 999 __
- $a ok $b bmc $g 1199936 $s 974249
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 33 $c 3 $d 224-234 $e 20161007 $i 1124-0490 $m Sarcoidosis vasculitis and diffuse lung diseases $n Sarcoidosis Vasc Diffuse Lung Dis $x MED00177336
- LZP __
- $a Pubmed-20170413